Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity

Eye (Basingstoke)

Volumn 26, Issue 7, 2012, Pages 903-910

  Lee, B J ^a,b   Kim, J H ^a,b   Heo, H ^c   Yu, Y S ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

anti VEGF; bevacizumab; retinopathy of prematurity; tractional retinal detachment

Indexed keywords

BEVACIZUMAB;

ARTICLE; ATYPICAL FIBROUS RETINAL TRACTION BAND; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; INFANT; LASER COAGULATION; MALE; MEDICAL RECORD REVIEW; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

EID: 84863859706     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.111     Document Type: Article

References (16)

1. Budd SJ, Thompson H, Hartnett ME. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity. Arch Ophthalmol 2010; 128: 1014-1021.
2. Weidemann A, Krohne TU, Aguilar E, Kurihara T, Takeda N, Dorrell MI et al. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 2010; 58: 1177-1185.
3. Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol 2000; 156: 1337-1344. (Pubitemid 30660011)
4. Sato T, Kusaka S, Shimojo H, Fujikado T. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology 2009; 116: 2165-2169.
5. Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D et al. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 2008; 28(3 Suppl): 13-18.
6. Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 2008; 28(3 Suppl): 19-25.
7. Honda S, Hirabayashi H, Tsukahara Y, Negi A. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1061-1063.
8. Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 2008; 92: 1450-1455.
9. Lee JY, Chae JB, Yang SJ, Yoon YH, Kim JG. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels. Graefes Arch Clin Exp Ophthalmol 248: 1257-1262.
10. Chung EJ, Kim JH, Ahn HS, Koh HJ. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1727-1730. (Pubitemid 47491565)
11. Mintz-Hittner HA, Kuffel Jr. RR. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 2008; 28: 831-838.
12. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364: 603-615.
13. Wu WC, Yeh PT, Chen SN, Yang CM, Lai CC, Kuo HK. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a Multicenter Study in Taiwan. Ophthalmology 2011; 118: 176-183.
14. Zepeda-Romero LC, Liera-Garcia JA, Gutierrez-Padilla JA, Valtierra-Santiago CI, Cardenas-Lamas LJ. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity. Eye (Lond) 2010; 24: 931-933.
15. Jang SY, Choi KS, Lee SJ. Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity. J AAPOS 2010; 14: 457-459.
16. Suk KK, Berrocal AM, Murray TG, Rich R, Major JC, Hess D et al. Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2010; 47, Online 1-4.